PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery
Clinical trial NCT00276523 · COMPLETED
Trial details
- NCT number
- NCT00276523
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2006-03-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.